The global Critical Care Drug market size was valued at US$ 23.45 billion in 2024 and is projected to reach US$ 34.56 billion by 2030, at a CAGR of 6.7% during the forecast period 2024-2030.
United States Critical Care Drug market size was valued at US$ 6.78 billion in 2024 and is projected to reach US$ 9.67 billion by 2030, at a CAGR of 6.1% during the forecast period 2024-2030.
Report Overview
Critical care drugs are the drugs used in an emergency, which helps to treat major injuries and illness.
This report provides a deep insight into the global Critical Care Drug market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Critical Care Drug Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Critical Care Drug market in any manner.
Global Critical Care Drug Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
- Pfizer
- Abbott
- Cadila Pharmaceuticals
- Haffkine Bio-Pharmaceutical
- Neon Laboratories
- Cambrex
Market Segmentation (by Type)
- Opioids
- Sedatives
- Benzodiazepines
- Others
Market Segmentation (by Application)
- Operation Theatre
- Intensive Care Unit
- Others
Geographic Segmentation
- North America (USA, Canada, Mexico)
- Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
- South America (Brazil, Argentina, Columbia, Rest of South America)
- The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
- Industry drivers, restraints, and opportunities covered in the study
- Neutral perspective on the market performance
- Recent industry trends and developments
- Competitive landscape & strategies of key players
- Potential & niche segments and regions exhibiting promising growth covered
- Historical, current, and projected market size, in terms of value
- In-depth analysis of the Critical Care Drug Market
- Overview of the regional outlook of the Critical Care Drug Market:
Key Reasons to Buy this Report:
Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
This enables you to anticipate market changes to remain ahead of your competitors
You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
Provision of market value (USD Billion) data for each segment and sub-segment
Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
Competitive landscape which incorporates the market ranking of the
major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Includes in-depth analysis of the market from various perspectives through Porter
TABLE OF CONTENTS
Table of Contents
1 Research Methodology and Statistical Scope
1.1 Market Definition and Statistical Scope of Critical Care Drug
1.2 Key Market Segments
1.2.1 Critical Care Drug Segment by Type
1.2.2 Critical Care Drug Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 Critical Care Drug Market Overview
2.1 Global Market Overview
2.1.1 Global Critical Care Drug Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global Critical Care Drug Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 Critical Care Drug Market Competitive Landscape
3.1 Global Critical Care Drug Sales by Manufacturers (2019-2024)
3.2 Global Critical Care Drug Revenue Market Share by Manufacturers (2019-2024)
3.3 Critical Care Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Critical Care Drug Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Critical Care Drug Sales Sites, Area Served, Product Type
3.6 Critical Care Drug Market Competitive Situation and Trends
3.6.1 Critical Care Drug Market Concentration Rate
3.6.2 Global 5 and 10 Largest Critical Care Drug Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 Critical Care Drug Industry Chain Analysis
4.1 Critical Care Drug Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 The Development and Dynamics of Critical Care Drug Market
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 Critical Care Drug Market Segmentation by Type
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Critical Care Drug Sales Market Share by Type (2019-2024)
6.3 Global Critical Care Drug Market Size Market Share by Type (2019-2024)
6.4 Global Critical Care Drug Price by Type (2019-2024)
7 Critical Care Drug Market Segmentation by Application
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Critical Care Drug Market Sales by Application (2019-2024)
7.3 Global Critical Care Drug Market Size (M USD) by Application (2019-2024)
7.4 Global Critical Care Drug Sales Growth Rate by Application (2019-2024)
8 Critical Care Drug Market Segmentation by Region
8.1 Global Critical Care Drug Sales by Region
8.1.1 Global Critical Care Drug Sales by Region
8.1.2 Global Critical Care Drug Sales Market Share by Region
8.2 North America
8.2.1 North America Critical Care Drug Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Critical Care Drug Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Critical Care Drug Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Critical Care Drug Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Critical Care Drug Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 Key Companies Profile
9.1 Pfizer
9.1.1 Pfizer Critical Care Drug Basic Information
9.1.2 Pfizer Critical Care Drug Product Overview
9.1.3 Pfizer Critical Care Drug Product Market Performance
9.1.4 Pfizer Business Overview
9.1.5 Pfizer Critical Care Drug SWOT Analysis
9.1.6 Pfizer Recent Developments
9.2 Abbott
9.2.1 Abbott Critical Care Drug Basic Information
9.2.2 Abbott Critical Care Drug Product Overview
9.2.3 Abbott Critical Care Drug Product Market Performance
9.2.4 Abbott Business Overview
9.2.5 Abbott Critical Care Drug SWOT Analysis
9.2.6 Abbott Recent Developments
9.3 Cadila Pharmaceuticals
9.3.1 Cadila Pharmaceuticals Critical Care Drug Basic Information
9.3.2 Cadila Pharmaceuticals Critical Care Drug Product Overview
9.3.3 Cadila Pharmaceuticals Critical Care Drug Product Market Performance
9.3.4 Cadila Pharmaceuticals Critical Care Drug SWOT Analysis
9.3.5 Cadila Pharmaceuticals Business Overview
9.3.6 Cadila Pharmaceuticals Recent Developments
9.4 Haffkine Bio-Pharmaceutical
9.4.1 Haffkine Bio-Pharmaceutical Critical Care Drug Basic Information
9.4.2 Haffkine Bio-Pharmaceutical Critical Care Drug Product Overview
9.4.3 Haffkine Bio-Pharmaceutical Critical Care Drug Product Market Performance
9.4.4 Haffkine Bio-Pharmaceutical Business Overview
9.4.5 Haffkine Bio-Pharmaceutical Recent Developments
9.5 Neon Laboratories
9.5.1 Neon Laboratories Critical Care Drug Basic Information
9.5.2 Neon Laboratories Critical Care Drug Product Overview
9.5.3 Neon Laboratories Critical Care Drug Product Market Performance
9.5.4 Neon Laboratories Business Overview
9.5.5 Neon Laboratories Recent Developments
9.6 Cambrex
9.6.1 Cambrex Critical Care Drug Basic Information
9.6.2 Cambrex Critical Care Drug Product Overview
9.6.3 Cambrex Critical Care Drug Product Market Performance
9.6.4 Cambrex Business Overview
9.6.5 Cambrex Recent Developments
10 Critical Care Drug Market Forecast by Region
10.1 Global Critical Care Drug Market Size Forecast
10.2 Global Critical Care Drug Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Critical Care Drug Market Size Forecast by Country
10.2.3 Asia Pacific Critical Care Drug Market Size Forecast by Region
10.2.4 South America Critical Care Drug Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Critical Care Drug by Country
11 Forecast Market by Type and by Application (2025-2030)
11.1 Global Critical Care Drug Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of Critical Care Drug by Type (2025-2030)
11.1.2 Global Critical Care Drug Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of Critical Care Drug by Type (2025-2030)
11.2 Global Critical Care Drug Market Forecast by Application (2025-2030)
11.2.1 Global Critical Care Drug Sales (K Units) Forecast by Application
11.2.2 Global Critical Care Drug Market Size (M USD) Forecast by Application (2025-2030)
12 Conclusion and Key Findings
LIST OF TABLES & FIGURES
List of Tables
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Critical Care Drug Market Size Comparison by Region (M USD)
Table 5. Global Critical Care Drug Sales (K Units) by Manufacturers (2019-2024)
Table 6. Global Critical Care Drug Sales Market Share by Manufacturers (2019-2024)
Table 7. Global Critical Care Drug Revenue (M USD) by Manufacturers (2019-2024)
Table 8. Global Critical Care Drug Revenue Share by Manufacturers (2019-2024)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Critical Care Drug as of 2022)
Table 10. Global Market Critical Care Drug Average Price (USD/Unit) of Key Manufacturers (2019-2024)
Table 11. Manufacturers Critical Care Drug Sales Sites and Area Served
Table 12. Manufacturers Critical Care Drug Product Type
Table 13. Global Critical Care Drug Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Critical Care Drug
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Critical Care Drug Market Challenges
Table 22. Global Critical Care Drug Sales by Type (K Units)
Table 23. Global Critical Care Drug Market Size by Type (M USD)
Table 24. Global Critical Care Drug Sales (K Units) by Type (2019-2024)
Table 25. Global Critical Care Drug Sales Market Share by Type (2019-2024)
Table 26. Global Critical Care Drug Market Size (M USD) by Type (2019-2024)
Table 27. Global Critical Care Drug Market Size Share by Type (2019-2024)
Table 28. Global Critical Care Drug Price (USD/Unit) by Type (2019-2024)
Table 29. Global Critical Care Drug Sales (K Units) by Application
Table 30. Global Critical Care Drug Market Size by Application
Table 31. Global Critical Care Drug Sales by Application (2019-2024) & (K Units)
Table 32. Global Critical Care Drug Sales Market Share by Application (2019-2024)
Table 33. Global Critical Care Drug Sales by Application (2019-2024) & (M USD)
Table 34. Global Critical Care Drug Market Share by Application (2019-2024)
Table 35. Global Critical Care Drug Sales Growth Rate by Application (2019-2024)
Table 36. Global Critical Care Drug Sales by Region (2019-2024) & (K Units)
Table 37. Global Critical Care Drug Sales Market Share by Region (2019-2024)
Table 38. North America Critical Care Drug Sales by Country (2019-2024) & (K Units)
Table 39. Europe Critical Care Drug Sales by Country (2019-2024) & (K Units)
Table 40. Asia Pacific Critical Care Drug Sales by Region (2019-2024) & (K Units)
Table 41. South America Critical Care Drug Sales by Country (2019-2024) & (K Units)
Table 42. Middle East and Africa Critical Care Drug Sales by Region (2019-2024) & (K Units)
Table 43. Pfizer Critical Care Drug Basic Information
Table 44. Pfizer Critical Care Drug Product Overview
Table 45. Pfizer Critical Care Drug Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 46. Pfizer Business Overview
Table 47. Pfizer Critical Care Drug SWOT Analysis
Table 48. Pfizer Recent Developments
Table 49. Abbott Critical Care Drug Basic Information
Table 50. Abbott Critical Care Drug Product Overview
Table 51. Abbott Critical Care Drug Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 52. Abbott Business Overview
Table 53. Abbott Critical Care Drug SWOT Analysis
Table 54. Abbott Recent Developments
Table 55. Cadila Pharmaceuticals Critical Care Drug Basic Information
Table 56. Cadila Pharmaceuticals Critical Care Drug Product Overview
Table 57. Cadila Pharmaceuticals Critical Care Drug Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 58. Cadila Pharmaceuticals Critical Care Drug SWOT Analysis
Table 59. Cadila Pharmaceuticals Business Overview
Table 60. Cadila Pharmaceuticals Recent Developments
Table 61. Haffkine Bio-Pharmaceutical Critical Care Drug Basic Information
Table 62. Haffkine Bio-Pharmaceutical Critical Care Drug Product Overview
Table 63. Haffkine Bio-Pharmaceutical Critical Care Drug Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 64. Haffkine Bio-Pharmaceutical Business Overview
Table 65. Haffkine Bio-Pharmaceutical Recent Developments
Table 66. Neon Laboratories Critical Care Drug Basic Information
Table 67. Neon Laboratories Critical Care Drug Product Overview
Table 68. Neon Laboratories Critical Care Drug Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 69. Neon Laboratories Business Overview
Table 70. Neon Laboratories Recent Developments
Table 71. Cambrex Critical Care Drug Basic Information
Table 72. Cambrex Critical Care Drug Product Overview
Table 73. Cambrex Critical Care Drug Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 74. Cambrex Business Overview
Table 75. Cambrex Recent Developments
Table 76. Global Critical Care Drug Sales Forecast by Region (2025-2030) & (K Units)
Table 77. Global Critical Care Drug Market Size Forecast by Region (2025-2030) & (M USD)
Table 78. North America Critical Care Drug Sales Forecast by Country (2025-2030) & (K Units)
Table 79. North America Critical Care Drug Market Size Forecast by Country (2025-2030) & (M USD)
Table 80. Europe Critical Care Drug Sales Forecast by Country (2025-2030) & (K Units)
Table 81. Europe Critical Care Drug Market Size Forecast by Country (2025-2030) & (M USD)
Table 82. Asia Pacific Critical Care Drug Sales Forecast by Region (2025-2030) & (K Units)
Table 83. Asia Pacific Critical Care Drug Market Size Forecast by Region (2025-2030) & (M USD)
Table 84. South America Critical Care Drug Sales Forecast by Country (2025-2030) & (K Units)
Table 85. South America Critical Care Drug Market Size Forecast by Country (2025-2030) & (M USD)
Table 86. Middle East and Africa Critical Care Drug Consumption Forecast by Country (2025-2030) & (Units)
Table 87. Middle East and Africa Critical Care Drug Market Size Forecast by Country (2025-2030) & (M USD)
Table 88. Global Critical Care Drug Sales Forecast by Type (2025-2030) & (K Units)
Table 89. Global Critical Care Drug Market Size Forecast by Type (2025-2030) & (M USD)
Table 90. Global Critical Care Drug Price Forecast by Type (2025-2030) & (USD/Unit)
Table 91. Global Critical Care Drug Sales (K Units) Forecast by Application (2025-2030)
Table 92. Global Critical Care Drug Market Size Forecast by Application (2025-2030) & (M USD)
List of Figures
Figure 1. Product Picture of Critical Care Drug
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Critical Care Drug Market Size (M USD), 2019-2030
Figure 5. Global Critical Care Drug Market Size (M USD) (2019-2030)
Figure 6. Global Critical Care Drug Sales (K Units) & (2019-2030)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Critical Care Drug Market Size by Country (M USD)
Figure 11. Critical Care Drug Sales Share by Manufacturers in 2023
Figure 12. Global Critical Care Drug Revenue Share by Manufacturers in 2023
Figure 13. Critical Care Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Critical Care Drug Average Price (USD/Unit) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Critical Care Drug Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Critical Care Drug Market Share by Type
Figure 18. Sales Market Share of Critical Care Drug by Type (2019-2024)
Figure 19. Sales Market Share of Critical Care Drug by Type in 2023
Figure 20. Market Size Share of Critical Care Drug by Type (2019-2024)
Figure 21. Market Size Market Share of Critical Care Drug by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Critical Care Drug Market Share by Application
Figure 24. Global Critical Care Drug Sales Market Share by Application (2019-2024)
Figure 25. Global Critical Care Drug Sales Market Share by Application in 2023
Figure 26. Global Critical Care Drug Market Share by Application (2019-2024)
Figure 27. Global Critical Care Drug Market Share by Application in 2023
Figure 28. Global Critical Care Drug Sales Growth Rate by Application (2019-2024)
Figure 29. Global Critical Care Drug Sales Market Share by Region (2019-2024)
Figure 30. North America Critical Care Drug Sales and Growth Rate (2019-2024) & (K Units)
Figure 31. North America Critical Care Drug Sales Market Share by Country in 2023
Figure 32. U.S. Critical Care Drug Sales and Growth Rate (2019-2024) & (K Units)
Figure 33. Canada Critical Care Drug Sales (K Units) and Growth Rate (2019-2024)
Figure 34. Mexico Critical Care Drug Sales (Units) and Growth Rate (2019-2024)
Figure 35. Europe Critical Care Drug Sales and Growth Rate (2019-2024) & (K Units)
Figure 36. Europe Critical Care Drug Sales Market Share by Country in 2023
Figure 37. Germany Critical Care Drug Sales and Growth Rate (2019-2024) & (K Units)
Figure 38. France Critical Care Drug Sales and Growth Rate (2019-2024) & (K Units)
Figure 39. U.K. Critical Care Drug Sales and Growth Rate (2019-2024) & (K Units)
Figure 40. Italy Critical Care Drug Sales and Growth Rate (2019-2024) & (K Units)
Figure 41. Russia Critical Care Drug Sales and Growth Rate (2019-2024) & (K Units)
Figure 42. Asia Pacific Critical Care Drug Sales and Growth Rate (K Units)
Figure 43. Asia Pacific Critical Care Drug Sales Market Share by Region in 2023
Figure 44. China Critical Care Drug Sales and Growth Rate (2019-2024) & (K Units)
Figure 45. Japan Critical Care Drug Sales and Growth Rate (2019-2024) & (K Units)
Figure 46. South Korea Critical Care Drug Sales and Growth Rate (2019-2024) & (K Units)
Figure 47. India Critical Care Drug Sales and Growth Rate (2019-2024) & (K Units)
Figure 48. Southeast Asia Critical Care Drug Sales and Growth Rate (2019-2024) & (K Units)
Figure 49. South America Critical Care Drug Sales and Growth Rate (K Units)
Figure 50. South America Critical Care Drug Sales Market Share by Country in 2023
Figure 51. Brazil Critical Care Drug Sales and Growth Rate (2019-2024) & (K Units)
Figure 52. Argentina Critical Care Drug Sales and Growth Rate (2019-2024) & (K Units)
Figure 53. Columbia Critical Care Drug Sales and Growth Rate (2019-2024) & (K Units)
Figure 54. Middle East and Africa Critical Care Drug Sales and Growth Rate (K Units)
Figure 55. Middle East and Africa Critical Care Drug Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Critical Care Drug Sales and Growth Rate (2019-2024) & (K Units)
Figure 57. UAE Critical Care Drug Sales and Growth Rate (2019-2024) & (K Units)
Figure 58. Egypt Critical Care Drug Sales and Growth Rate (2019-2024) & (K Units)
Figure 59. Nigeria Critical Care Drug Sales and Growth Rate (2019-2024) & (K Units)
Figure 60. South Africa Critical Care Drug Sales and Growth Rate (2019-2024) & (K Units)
Figure 61. Global Critical Care Drug Sales Forecast by Volume (2019-2030) & (K Units)
Figure 62. Global Critical Care Drug Market Size Forecast by Value (2019-2030) & (M USD)
Figure 63. Global Critical Care Drug Sales Market Share Forecast by Type (2025-2030)
Figure 64. Global Critical Care Drug Market Share Forecast by Type (2025-2030)
Figure 65. Global Critical Care Drug Sales Forecast by Application (2025-2030)
Figure 66. Global Critical Care Drug Market Share Forecast by Application (2025-2030)
